155 related articles for article (PubMed ID: 38689092)
1. Stress-induced epinephrine promotes hepatocellular carcinoma progression via the USP10-PLAGL2 signaling loop.
Wang C; Ni J; Zhai D; Xu Y; Wu Z; Chen Y; Liu N; Du J; Shen Y; Liu G; Yang Y; You L; Hu W
Exp Mol Med; 2024 May; 56(5):1150-1163. PubMed ID: 38689092
[TBL] [Abstract][Full Text] [Related]
2. PLAGL2-EGFR-HIF-1/2α Signaling Loop Promotes HCC Progression and Erlotinib Insensitivity.
Hu W; Zheng S; Guo H; Dai B; Ni J; Shi Y; Bian H; Li L; Shen Y; Wu M; Tian Z; Liu G; Hossain MA; Yang H; Wang D; Zhang Q; Yu J; Birnbaumer L; Feng J; Yu D; Yang Y
Hepatology; 2021 Feb; 73(2):674-691. PubMed ID: 32335942
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
[TBL] [Abstract][Full Text] [Related]
4. Selenium sulfide disrupts the PLAGL2/C-MET/STAT3-induced resistance against mitochondrial apoptosis in hepatocellular carcinoma.
Yang T; Huo J; Xu R; Su Q; Tang W; Zhang D; Zhu M; Zhan Y; Dai B; Zhang Y
Clin Transl Med; 2021 Sep; 11(9):e536. PubMed ID: 34586726
[TBL] [Abstract][Full Text] [Related]
5. 2-Methoxyestradiol synergizes with Erlotinib to suppress hepatocellular carcinoma by disrupting the PLAGL2-EGFR-HIF-1/2α signaling loop.
Zheng S; Ni J; Li Y; Lu M; Yao Y; Guo H; Jiao M; Jin T; Zhang H; Yuan A; Wang Z; Yang Y; Chen Z; Wu H; Hu W
Pharmacol Res; 2021 Jul; 169():105685. PubMed ID: 34022398
[TBL] [Abstract][Full Text] [Related]
6. Hsa-circRNA-103809 Promotes Hepatocellular Carcinoma Development via MicroRNA-1270/PLAG1 Like Zinc Finger 2 Axis.
Cao Y; Tao Q; Kao X; Zhu X
Dig Dis Sci; 2021 May; 66(5):1524-1532. PubMed ID: 32683589
[TBL] [Abstract][Full Text] [Related]
7. USP10 suppresses tumor progression by inhibiting mTOR activation in hepatocellular carcinoma.
Lu C; Ning Z; Wang A; Chen D; Liu X; Xia T; Tekcham DS; Wang W; Li T; Liu X; Liu J; Qi H; Luo H; Du J; Ma C; Yan Q; Liu J; Xu G; Piao HL; Tan G
Cancer Lett; 2018 Nov; 436():139-148. PubMed ID: 30056112
[TBL] [Abstract][Full Text] [Related]
8. PLAGL2 promotes the proliferation and migration of gastric cancer cells via USP37-mediated deubiquitination of Snail1.
Wu L; Zhao N; Zhou Z; Chen J; Han S; Zhang X; Bao H; Yuan W; Shu X
Theranostics; 2021; 11(2):700-714. PubMed ID: 33391500
[No Abstract] [Full Text] [Related]
9. Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein.
Yuan T; Chen Z; Yan F; Qian M; Luo H; Ye S; Cao J; Ying M; Dai X; Gai R; Yang B; He Q; Zhu H
Mol Oncol; 2020 Jan; 14(1):197-210. PubMed ID: 31721429
[TBL] [Abstract][Full Text] [Related]
10. USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ.
Zhu H; Yan F; Yuan T; Qian M; Zhou T; Dai X; Cao J; Ying M; Dong X; He Q; Yang B
Cancer Res; 2020 Jun; 80(11):2204-2216. PubMed ID: 32217697
[TBL] [Abstract][Full Text] [Related]
11. The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression.
Zhao Z; Shelton SD; Oviedo A; Baker AL; Bryant CP; Omidvarnia S; Du L
J Exp Clin Cancer Res; 2020 Feb; 39(1):41. PubMed ID: 32087738
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin.
Cai S; Bai Y; Wang H; Zhao Z; Ding X; Zhang H; Zhang X; Liu Y; Jia Y; Li Y; Chen S; Zhou H; Liu H; Yang C; Sun T
J Exp Clin Cancer Res; 2020 Jul; 39(1):135. PubMed ID: 32669125
[TBL] [Abstract][Full Text] [Related]
13. UCHL5 promotes hepatocellular carcinoma progression by promoting glycolysis through activating Wnt/β-catenin pathway.
Wan B; Cheng M; He T; Zhang L
BMC Cancer; 2024 May; 24(1):618. PubMed ID: 38773433
[TBL] [Abstract][Full Text] [Related]
14. LncRNA GASAL1 promotes hepatocellular carcinoma progression by up-regulating USP10-stabilized PCNA.
Shen C; Li J; Zhang Q; Tao Y; Li R; Ma Z; Wang Z
Exp Cell Res; 2022 Jun; 415(1):112973. PubMed ID: 34914965
[TBL] [Abstract][Full Text] [Related]
15. Discovery of potent small molecule ubiquitin-specific protease 10 inhibitors with anti-hepatocellular carcinoma activity through regulating YAP expression.
Lu Y; Gao J; Wang P; Chen H; He X; Luo M; Guo Y; Li L; Zhuang W; Zhang B; Lin N; Li J; Zhou Y; Dong X; Che J
Eur J Med Chem; 2024 Jun; 272():116468. PubMed ID: 38718626
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.
Wang JL; Yang MY; Xiao S; Sun B; Li YM; Yang LY
J Exp Clin Cancer Res; 2018 Mar; 37(1):45. PubMed ID: 29506567
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-specific protease 2a promotes hepatocellular carcinoma progression via deubiquitination and stabilization of RAB1A.
Xiong B; Huang J; Liu Y; Zou M; Zhao Z; Gong J; Wu X; Qiu C
Cell Oncol (Dordr); 2021 Apr; 44(2):329-343. PubMed ID: 33074477
[TBL] [Abstract][Full Text] [Related]
18. PLAGL2 promotes epithelial-mesenchymal transition and mediates colorectal cancer metastasis via β-catenin-dependent regulation of ZEB1.
Wu L; Zhou Z; Han S; Chen J; Liu Z; Zhang X; Yuan W; Ji J; Shu X
Br J Cancer; 2020 Feb; 122(4):578-589. PubMed ID: 31827238
[TBL] [Abstract][Full Text] [Related]
19. Overexpressed PLAGL2 transcriptionally activates Wnt6 and promotes cancer development in colorectal cancer.
Li N; Li D; Du Y; Su C; Yang C; Lin C; Li X; Hu G
Oncol Rep; 2019 Feb; 41(2):875-884. PubMed ID: 30535429
[TBL] [Abstract][Full Text] [Related]
20. The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs.
Zhang T; Wan C; Shi W; Xu J; Fan H; Zhang S; Lin Z; Ni R; Zhang X
J Mol Histol; 2015 Dec; 46(6):485-97. PubMed ID: 26438629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
